Li Jianjun, Zhang Yinghui, Wang Xiuchao, Zhao Ruibo
Department of Ophthalmology, Xi'an XD Group Hospital, Xi'an, Shaanxi 710077, P.R. China.
Refractive Surgery Center, Xi'an Aier Ancient City Eye Hospital, Xi'an, Shaanxi 710061, P.R. China.
Oncol Lett. 2017 Jun;13(6):5021-5027. doi: 10.3892/ol.2017.6083. Epub 2017 Apr 24.
The expression level and roles of microRNA-497 (miR-497) have been frequently reported in previous studies on cancer. However, its expression, function and associated molecular mechanisms in retinoblastoma remain unknown. In the present study, miR-497 expression levels in human retinoblastoma tissues, normal retinal tissues and retinoblastoma cell lines were determined using reverse transcription-quantitative polymerase chain reaction. In addition, a Cell Counting Kit-8 assay, cell migration assay, cell invasion assay, western blot analysis and Dual-Luciferase reporter assay were used to explore the expression, functions and molecular mechanisms of miR-497 in human retinoblastoma. It was demonstrated that miR-497 was significantly downregulated in retinoblastoma tissues and cell lines compared with normal retinal tissues. Ectopic expression of miR-497 decreased the proliferation, migration and invasion of retinoblastoma cells. Furthermore, VEGFA was verified as a potential direct target of miR-497 . Taken together, the results indicate that miR-497 functions as a tumor suppressor in the carcinogenesis and progression of retinoblastoma via targeting VEGFA. miR-497 should be investigated as a potential therapeutic target for the treatment of retinoblastoma.
在以往关于癌症的研究中,经常报道微小RNA - 497(miR - 497)的表达水平及其作用。然而,其在视网膜母细胞瘤中的表达、功能及相关分子机制仍不清楚。在本研究中,采用逆转录 - 定量聚合酶链反应测定人视网膜母细胞瘤组织、正常视网膜组织及视网膜母细胞瘤细胞系中miR - 497的表达水平。此外,使用细胞计数试剂盒 - 8检测、细胞迁移检测、细胞侵袭检测、蛋白质印迹分析和双荧光素酶报告基因检测来探究miR - 497在人视网膜母细胞瘤中的表达、功能及分子机制。结果表明,与正常视网膜组织相比,视网膜母细胞瘤组织和细胞系中miR - 497显著下调。miR - 497的异位表达降低了视网膜母细胞瘤细胞的增殖、迁移和侵袭能力。此外,血管内皮生长因子A(VEGFA)被证实为miR - 497的潜在直接靶点。综上所述,结果表明miR - 497通过靶向VEGFA在视网膜母细胞瘤的发生和发展中发挥肿瘤抑制作用。应将miR - 497作为视网膜母细胞瘤治疗的潜在治疗靶点进行研究。